Feb 5, 2025 8:00am EST Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment
Jan 22, 2025 8:00am EST Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
December 20, 2023 Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach
June 14, 2023 Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO